Topical Ophthalmic Administration of VIAN-c4551 Antiangiogenic Peptide for Diabetic Macular Edema: Preclinical Efficacy and Ocular Pharmacokinetics
Elva Adán‐Castro, Magdalena Zamora, Daniela Granados-Carrasco, Lourdes Siqueiros‐Márquez, José Fernando García-Rodrigo, Fernando Macías, Thomas Bertsch, Jakob Triebel, Edith Arnold, Gonzalo Martı́nez de la Escalera, Juan Pablo Robles, Carmen Clapp
This study evaluates VIAN-c4551 eye drops for treating diabetic macular edema, showing they reach therapeutic concentrations in the retina and reduce vascular leakage.
Scientific Reports · Jul 23, 2025Peer-reviewedPharmacology & Toxicology